Secretory phospholipase A2 pathway in various types of lung injury in neonates and infants: A multicentre translational study

BMC Pediatrics

Volumn 11, Issue , 2011, Pages

  De Luca, Daniele ^a   Capoluongo, Ettore ^a,c   Rigo, Vincent ^b   De Luca, D ^c   Minucci, A ^c   Vendittelli, F ^c   Tripodi, D ^c   Gentile, L ^c   Zuppi, C ^c   Giardina, B ^c   Antonelli, M ^c   Conti, G ^c   Pietrini, D ^c   Piastra, M ^c   Cools, F ^c   Camfferman, F ^c   Rigo, V ^c   Carbajosa, J T ^c   Remesal, A ^c   Sanfeliciano, L ^c   Zaballos, M F Benito ^c   more..

^a FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^b UNIVERSITY OF LIÈGE   (Belgium)

^c NONE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID; HYALIN; INTERLEUKIN 1BETA; LUNG SURFACTANT; SECRETORY PHOSPHOLIPASE A2; TUMOR NECROSIS FACTOR ALPHA; DNA;

ACUTE LUNG INJURY; ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; CATABOLISM; DISEASE COURSE; HUMAN; HYALINE MEMBRANE DISEASE; INFANT DISEASE; LUNG LAVAGE; MECONIUM ASPIRATION; MULTICENTER STUDY (TOPIC); NEWBORN DISEASE; NEWBORN INTENSIVE CARE; OUTCOME ASSESSMENT; RESPIRATORY FAILURE; RESPIRATORY TRACT INFECTION; SEPSIS; BIOSYNTHESIS; CHEMISTRY; CLINICAL TRIAL; COMPARATIVE STUDY; DOSE RESPONSE; ENZYMOLOGY; FEMALE; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; INFANT; LUNG INJURY; MULTICENTER STUDY; NEWBORN; POLYMERASE CHAIN REACTION; PREGNANCY;

BRONCHOALVEOLAR LAVAGE FLUID; DNA; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GENOTYPE; HUMANS; INFANT; INFANT, NEWBORN; INTENSIVE CARE UNITS, NEONATAL; LUNG INJURY; PHOSPHOLIPASES A2, SECRETORY; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PREGNANCY; PULMONARY SURFACTANTS;

EID: 80455158281     PISSN: None     EISSN: 14712431     Source Type: Journal    
DOI: 10.1186/1471-2431-11-101     Document Type: Article

References (70)

1. Kitsiouli E, Nakos G, Lekka ME. Phospholipase A2 subclasses in acute respiratory distress syndrome. Biochim Biophys Acta 2009, 1792:941-53.
2. Dennis EA. The growing phospholipase A2 superfamily of signal transduction enzymes. Trends Biochem Sci 1997, 22:1-2.
3. Triggiani M, Giannattasio G, Calabrese C, Loffredo S, Granata F, Fiorello A, Santini M, Gelb MH, Marone G. Lung mast cells are a source of secreted phospholipases A2. J Allergy Clin Immunol 2009, 124:558-565.
4. Touqui L, Arbibe L. A role for phospholipase A2 in ARDS pathogenesis. Mol Med Tod 1999, 5:244-249.
5. Nakos G, Kitsiouli E, Hatzidaki E, Koulouras V, Touqui L, Lekka ME. Phospholipases A2 and platelet activating-factor acetylhydrolase in patients with acute respiratory distress syndrome. Crit Care Med 2005, 33:772-779.
6. Wheeler DS. Phospholipases A2 and acute lung injury: it's just not that simple. Crit Care Med 2005, 33:904-5.
7. Berger A, Havet N, Vial D, Arbibe L, Dumarey C, Watson ML, Touqui L. Dioleylphosphatidylglicerol inhibits the expression of type II phospholiase A2 in macrophages. Am J Resp Crit Care Med 1999, 159:613-619.
8. Furue S, Kuwabara K, Mikawa K, Nishina K, Shiga M, Maekawa N, Ueno M, Chikazawa Y, Ono T, Hori Y, Matsukawa A, Yoshinaga M, Obara H. Crucial role for group II-phospholipase A2 in oleic acid-induced acute lung injury in rabbits. Am J Resp Crit Care Med 1999, 160:1292-1302.
9. Granata F, Frattini A, Loffredo S, Del Prete A, Sozzani S, Marone G, Triggiani M. Signaling events involved in cytokines and chemokines production induced by secretory phospholipase A2 in human lung macrophages. Eur J Immunol 2006, 36:1938-1950.
10. Kim DK, Fukuda T, Thompson BT, Cockrill B, Hales C, Bonventre JV. Bronchoalveolar lavage fluid phospholipase A2 activities are increased in human adult respiratory distress syndrome. Am J Physiol 1995, 269:L109-18.
11. De Luca D, Minucci A, Cogo P, Capoluongo ED, Conti G, Pietrini D, Carnielli VP, Piastra M. Secretory phospholipase A2 pathway during pediatric acute respiratory distress syndrome: A preliminary study. Pediatr Crit Care Med 2011, 12:e20-4.
12. Liu T, Zaman W, Kaphalia BS, Ansari GA, Garofalo RP, Casola A. RSV induced prostaglandin E2 production occurs via cPLA2 activation: Role in viral replication. Virology 2005, 343:12-24.
13. Wang SZ, Rosenberger CL, Bao YX, Stark JM, Harrod KS. Clara Cell secretory proteein modulates inflammatory and immune responses to respiratory syncitial virus infection. J Immunol 2003, 171:1051-60.
14. Furue S, Mikawa K, Nishina K, Shiga M, Ueno M, Tomita Y, Kuwabara K, Teshirogi I, Ono T, Hori Y, Matsukawa A, Yoshinaga M, Obara H. Therapeutic time-window of a group IIA-phospholipase A2 inhibitor in rabbit acute lung injury: correlation with lung surfactant protection. Crit Care Med 2001, 29:719-727.
15. De Luca D, Minucci A, Trias J, Tripodi D, Conti G, Zuppi C, Capoluongo E. Varespladib Inhibits Secretory Phospholipase A2 in Bronchoalveolar Lavage of Different Types of Neonatal Lung Injury. J Clin Pharmacol 2011,
16. Zecca E, De Luca D, Costa S, Marras M, Romagnoli C. Neonatal Intensive Care and outcomes of extremely preterm infants: changes over a decade. Ital J Pediatr 2006, 32:48-54.
17. Van Marter LJ. Epidemiology of bronchopulmonary dysplasia. Semin Fetal Neonatal Med 2009, 14:358-66.
18. Speer CP. Chorioamnionitis, postnatal factors and proinflammatory response in the pathogenetic sequence of bronchopulmonary dysplasia. Neonatology 2009, 95:353-61.
19. De Luca D, Baroni S, Vento G, Piastra M, Pietrini D, Romitelli F, Capoluongo E, Romagnoli C, Conti G, Zecca E. Secretory phospholipase A2 and neonatal respiratory distress. Pilot study on broncho-alveolar lavage. Intensive Care Med 2008, 34:1858-64.
20. Schrama AJJ, Elferink JGR, Hack CE, de Beaufort AJ, Berger HM, Walther FS. Pulmonary secretory phospholipase A2 in infants with respiratory distress syndrome stimulates in vitro neutrophil migration. Neonatology 2010, 97:1-9.
21. Levine CR, Gewolb IH, Allen K, Welch RW, Melby JM, Pollack S, Shaffer T, Pilon AL, Davis JM. The safety, pharmacokinetics, and anti-inflammatory effects of intratracheal recombinant human Clara cell protein in premature infants with respiratory distress syndrome. Pediatr Res 2005, 58:15-21.
22. Welty SE. CC10 administration to premature infants: in search of the "silver bullet" to prevent lung inflammation. Pediatr Res 2005, 58:7-9.
23. Chandra S, Davis JM, Drexler S, Kowalewska J, Chester D, Koo HC, Pollack S, Welch R, Pilon A, Levine CR. Safety and efficacy of intratracheal recombinant human Clara cell protein in a newborn piglet model of acute lung injury. Pediatr Res 2003, 54:509-515.
24. Angert RM, Pilon AL, Chester D, Davis JM. CC10 reduces inflammation in meconium aspiration syndrome in newborn piglets. Pediatr Res 2007, 62:684-688.
25. Shashikant BN, Miller TL, Welch RW, Pilon AL, Shaffer TH, Wolfson MR. Dose response to rhCC10-augmented surfactant therapy in a lamb model of infant respiratory distress syndrome: physiological, inflammatory, and kinetic profiles. J Appl Physiol 2005, 99:2204-11.
26. Yeh TF, Lin HC, Chang C, Wu TS, Su BH, Li TC, Pyati S, Tsai CH. Early intratracheal instillation of budesonide using surfactant as vehicle to prevent chronic lung disease in preterm infants: a pilot study. Pediatrics 2008, 121:e1310-1318.
27. Triggiani M, Granata F, Petraroli A, Loffredo S, Frattini A, Staiano RI, Monaco G, Marone G. Inhibition of secretory phospholipase A2-induced cytokine production in human lung macrophages by budesonide. Int Arch Allergy Immunol 2009, 150:144-55.
28. Khammash H, Perlman M, Wojtulewicz J, Dunn M. Surfactant therapy in full-term neonates with severe respiratory failure. Pediatrics 1993, 92:135-139.
29. Herting E, Gefeller O, Land M, van Sonderen L, Harms K, Robertson B, . Members of the Collaborative European Multicenter Study Group Surfactant treatment of neonates with respiratory failure and group B streptococcal infection. Pediatrics 2000, 106:957-964. Members of the Collaborative European Multicenter Study Group.
30. Schrama AJJ, de Beaufort AJ, Sukul YR, Jansen SM, Poorthuis BJ, Berger HM. Phospholipase A2 is present in meconium and inhibits the activity of pulmonary surfactant: an in vitro study. Acta Paediatr 2001, 90:412-416.
31. Sippola T, Aho H, Peuravuori H, Lukkarinen H, Gunn J, Kaapa P. Pancreatic phospholipase A2 contributes to lung injury in experimental meconium aspiration. Pediatr Res 2006, 59:641-645.
32. Kaapa P, Soukka H. Phospholipase A2 in meconium-induced lung injury. J Perinat 2008, 28:S120-S122.
33. De Luca D, Minucci A, Zecca E, Piastra M, Pietrini D, Carnielli VP, Zuppi C, Tridente A, Conti G, Capoluongo E. Bile acids cause secretory phospholipase A2 activity enhancement, revertible by exogenous surfactant administration. Intensive Care Med 2009, 35:321-6.
34. Korhonen K, Soukka H, Halkola L, Peuravuori H, Aho H, Pulkki K, Kero P, Kaapa PO. Meconium induces only localised inflammatory lung injury in piglets. Pediatr Res 2003, 54:192-7.
35. Salvesen B, Stenvik J, Rossetti C, Saugstad OD, Espevik T, Mollnes TE. Meconium-induced release of cytokines is mediatd by TLR4/MD2 complex in a CD14-dependent manner. Mol Immunol 2010, 47:1226-1234.
36. Granata F, Petraroli A, Boilard E, Bezzine S, Bollinger J, Del Vecchio L, Gelb MH, Lambeau G, Marone G, Triggiani M. Activation of cytokine production by secreted phospholipase A2 in human lung macrophages expressing the M-type receptor. J Immunol 2005, 174:464-474.
37. Vidyasagar D, Bhat R, Uhal B, Navale S, Zagariya A. TNFα, IL1β, IL6, IL8, IFNγ, PGE2 and IL10 expression in meconium aspirated newborn lungs [abstract]. Pediatr Res 1999, 45:325A.
38. Hurley BP, McCormick BA. Multiple roles of phospholipase A2 during lung infection and inflammation. Infect Immun 2008, 76:2259-72.
39. De Luca D, Minucci A, Tripodi D, Piastra M, Pietrini D, Zuppi C, Conti G, Carnielli VP, Capoluongo E. Role of distinct phospholipases A2 and their modulators in meconium aspiration syndrome in human neonates. Intensive Care Med 2011, 37:1158-65.
40. Brown KL, Sriram S, Ridout D, Cassidy J, Pandya H, Liddell M, Davis C, Goldman A, Field D, Karimova A. Extracorporeal membrane oxygenation and term neonatal respiratory failure deaths in the United Kingdom compared with the United States: 1999 to 2005. Pediatr Crit Care Med 2010, 11:60-5.
41. Dargaville PA, Copnell B, Mills JF, Haron I, Lee JK, Tingay DG, Rohana J, Mildenhall LF, Jeng MJ, Narayanan A, Battin MR, Kuschel CA, Sadowsky JL, Patel H, Kilburn CJ, Carlin JB, Morley CJ, . lessMAS Trial Study Group Randomized controlled trial of lung lavage with dilute surfactant for meconium aspiration syndrome. J Pediatr 2011, 158:383-389.e2. lessMAS Trial Study Group.
42. Zecca E, De Luca D, Baroni S, Vento G, Tiberi E, Romagnoli C. Bile acids induced lung injury: a broncho-alveolar lavage study. Pediatrics 2008, 121:e146-9.
43. Zecca E, De Luca D, Barbato G, Marras M, Tiberi E, Romagnoli C. Predicting respiratory distress syndrome in neonates from mothers with intrahepatic cholestasis of pregnancy. Early Hum Dev 2008, 84:337-41.
44. Zecca E, De Luca D, Marras M, Caruso A, Bernardini T, Romagnoli C. Intrahepatic cholestasis of pregnancy and neonatal respiratory distress syndrome. Pediatrics 2006, 117:1669-72.
45. Pan YH, Bahnson BJ. Structural basis for bile salt inhibition of pancreatic phospholipase A2. J Mol Biol 2007, 369:439-50.
46. Takabatake N, Sata M, Inoue S, Shibata Y, Abe S, Wada T, Machiya J, Ji G, Matsuura T, Takeishi Y, Muramatsu M, Kubota I. A novel polymorphism in secretory phospholipase A2-IID is associated with body weight loss in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005, 172:1097-104.
47. Gora S, Perret C, Jemel I, Nicaud V, Lambeau G, Cambien F, Niuvo E, Blankenberg S, Tiret L, Karabuke SA. Molecular and functional characterization of polymorphisms in the secreted phopsholipase A2 group × gene: relevance to coronary artery disease. J Mol Med 2009, 87:723-733.
48. Ohtsuki M, Taketomi Y, Arata S, Masuda S, Ishikawa Y, Ishii T, Takanezawa Y, Aoki J, Arai H, Yamamoto K, Kudo I, Muratami M. Transgenic expression of group V but not group × secreted phospholipase A2 in mice leads to neonatal lethality because of lung dysfunction. J Biol Chem 2006, 281:36420-33.
49. Muñoz NM, Meliton AY, Meliton LN, Dudek SM, Leff AR. Secretory group V phospholipase A2 regulates acute lung injury and neutrophilic inflammation caused by LPS in mice. Am J Physiol Lung Cell Mol Physiol 2009, 296:L879-87.
50. Curfs DMJ, Ghesquiere SAI, Vergouwe MN, van der Made I, Gijbels MJJ, Greaves DR, Sjef Verbeek J, Hofker MH, de Winther MPJ. Macrophage Secretory Phospholipase A2 Group × Enhances Anti-inflammatory Responses, Promotes Lipid Accumulation, and Contributes to Aberrant Lung Pathology. J Biol Chem 2008, 283:21640-8.
51. Randolph AG. Management of acute lung injury and acute respiratory distress syndrome in children. Crit Care Med 2009, 37:2448-54.
52. Zecca E, Barone G, Corsello M, Romagnoli C, Tiberi E, Tirone C, Vento G. Reliability of two different bedside assays for C-reactive protein in newborn infants. Clin Chem Lab Med 2009, 47:1081-1084.
53. Jacquot A, Labaune JM, Baum TP, Putet G, Picaud JC. Rapid quantitative procalcitonin measurement to diagnose nosocomial infections in newborn infants. Arch Dis Child Fetal Neonatal Ed 2009, 94:F345-8.
54. American Heart Association American Academy of Pediatrics 2005 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care of pediatric and neonatal patients: neonatal resuscitation guidelines. Pediatrics 2006, 117:1029-1038. American Heart Association American Academy of Pediatrics.
55. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, Legall JR, Morris A, Spragg R, . the Consensus Committee American-European Consensus Conference on ARDS. Definition, mechanisms, relevant outcomes and clinical trial coordination. Am J Respir Crit Care Med 1994, 149:818-824. the Consensus Committee.
56. European Respiratory Society Task Force on bronchoalveolar lavage in children Bronchoalveolar lavage in children. Eur Respir J 2000, 15:217-231. European Respiratory Society Task Force on bronchoalveolar lavage in children.
57. Scalfaro P, Pillow JJ, Sly PD, Cotting J. Reliable tidal volume estimates at the airway opening with an infant monitor during high-frequency oscillatory ventilation. Crit Care Med 2001, 29:1925-1930.
58. Chang HK. Mechanisms of gas transport during ventilation by high frequency oscillation. J Appl Physiol 1984, 56:553-564.
59. Jobe AH, Bancalari E. Bronchopulmonary displasia. NICHD/NHLBI/ORD Workshop Summary. Am J Respir Crit Care Med 2001, 163:1723-1729.
60. Berdat P, Wehrle TJ, Küng A, Achermann F, Sutter M, Carrel TP, Nydegger UE. Age-specific analysis of normal cytokine levels in healthy infants. Clin Chem Lab Med 2003, 4:1335-1339.
61. Coppens JT, Van Winkle LS, Pinkerton KE, Plopper CG. Distribution of Clara Cell Secretory Protein expression in the tracheobronchial airways of rhesus monkeys. Am J Physiol Lung Cell Mol Physiol 2007, 292:1155-1162.
62. Reynolds LJ, Hughes LL, Dennis EA. Analysis of human synovial fluid phospholipase A2 on short chain phosphatidylcholine-mixed micelles: development of a spectrophotometric assay suitable for a microtiter plate reader. Anal Biochem 1992, 204:190-197.
63. Reynolds LJ, Hughes LL, Yu L, Dennis EA. 1-Hexadecyl-2-arachidonoylthio-2-deoxy-sn-glycero-3-phosphorylcholine as a substrate for the microtiterplate assay of human cytosolic phospholipase A2. Anal Biochem 1994, 217:25-32.
64. Capoluongo E, Ameglio F, Lulli P, Minucci A, Santonocito C, Concolino P, Di Stasio E, Boccacci S, Vendettuoli V, Giuratrabocchetta G, De Cunto A, Tana M, Romagnoli C, Zuppi C, Vento G. Epithelial lining fluid free IGF-I-to-PAPP-A ratio is associated with bronchopulmonary dysplasia in preterm infants. Am J Physiol Endocrinol Metab 2007, 292:E308-E313.
65. Livak KJ. Allelic discrimination using fluorogenic probes and the 5' nuclease assay. Genet Anal 1999, 14:143-149.
66. Norusis M. SPSS 13.0 advanced statistical procedures companion. 2004, Prentice Hall: Upper Saddle-River.
67. Wildt AR, Ahtola OT. Analysis of covariance. Quantitative Applications in the Social Sciences, series 12 1978, Thousand Oaks, CA: Sage Publications, Hills, B.
68. Dupont WD, Plummer WD. Power and sample size calculations. A review and computer program. Control Clin Trials 1990, 11:116-28.
69. Garcia-Garcia HM, Serruys PW. Phospholipase A2 inhibitors. Curr Opin Lipidol 2009, 20:327-32.
70. De Luca D, Cogo P, Zecca E, Piastra M, Pietrini D, Tridente A, Conti G, Carnielli VP. Intrapulmonary drug administration in neonatal and paediatric critical care: a comprehensive review. Eur Respir J 2011, 37:678-89.